These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone. Cassidy EM; Tomkins E; Sharifi N; Dinan T; Hardiman O; O'Keane V Pain; 2003 Feb; 101(3):283-290. PubMed ID: 12583871 [TBL] [Abstract][Full Text] [Related]
3. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Olesen J Cephalalgia; 1997 Aug; 17(5):559. PubMed ID: 9251869 [No Abstract] [Full Text] [Related]
4. Effect of rizatriptan in the spectrum of headache. Allen C; Cady R; Lines C; McCarroll K Headache; 2001 Jun; 41(6):607-8. PubMed ID: 11437904 [No Abstract] [Full Text] [Related]
5. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Cady RK; Gutterman D; Saiers JA; Beach ME Cephalalgia; 1997 Aug; 17(5):588-90. PubMed ID: 9251874 [TBL] [Abstract][Full Text] [Related]
6. Providing relief from headache pain. Current options for acute and prophylactic therapy. Ward TN Postgrad Med; 2000 Sep; 108(3):121-8; quiz 26. PubMed ID: 11004939 [TBL] [Abstract][Full Text] [Related]
8. Serotonin syndrome from fluvoxamine and buspirone. Baetz M; Malcolm D Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727 [No Abstract] [Full Text] [Related]
9. Clinical efficacy of rizatriptan for patients with migraine: efficacy of drug therapy for migraine accompanied by tension headache-like symptoms, focusing on neck stiffness. Okuma H; Kitagawa Y; Takagi S J Headache Pain; 2005 Dec; 6(6):455-8. PubMed ID: 16388340 [TBL] [Abstract][Full Text] [Related]
10. [Triptans in migraine--here and now (15 years after they were implemented in therapy)]. Prusiński A; Rozniecki JJ Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S68-77. PubMed ID: 16419574 [TBL] [Abstract][Full Text] [Related]
11. Current concepts of the pathophysiology of migraine. Goadsby PJ Neurol Clin; 1997 Feb; 15(1):27-42. PubMed ID: 9058395 [TBL] [Abstract][Full Text] [Related]
13. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew. Goldstein D Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072 [No Abstract] [Full Text] [Related]
14. Buspirone, a serotonergic 5-HT1A agonist, is active in cerebellar ataxia. A new fact in favor of the serotonergic theory of ataxia. Trouillas P; Xie J; Adeleine P Prog Brain Res; 1997; 114():589-99. PubMed ID: 9193169 [TBL] [Abstract][Full Text] [Related]
15. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs]. Amelin AV; Skoromets AA; Ignatov IuD Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805 [No Abstract] [Full Text] [Related]
16. Treatment of acute migraine. Miller FG Lancet; 2002 Mar; 359(9308):802. PubMed ID: 11888631 [No Abstract] [Full Text] [Related]
17. Efficacy of 5HT in migraine. Buzzi MG Cephalalgia; 1999 Sep; 19(7):625-6. PubMed ID: 10524654 [No Abstract] [Full Text] [Related]
18. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy. Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951 [TBL] [Abstract][Full Text] [Related]
19. The neurologist-sufferer perspective: "migraine tears me away from my life". Carter D Drugs Today (Barc); 2003; 39 Suppl D():11-6. PubMed ID: 15071615 [TBL] [Abstract][Full Text] [Related]
20. IS 159. Drugs R D; 1999 Dec; 2(6):390-1. PubMed ID: 10763448 [No Abstract] [Full Text] [Related] [Next] [New Search]